Malaria remains one of the most serious health problems worldwide and is responsible for between one and three million deaths annually. Even if the current trend towards a reduction of malaria incidence as a result of better anti-malarial drugs and intensified use of effective control measures continues, the situation is fragile due to the spread of drug-resistant parasites and insecticide-resistant vectors.
This meeting will explore important recent findings in parasite and vector biology, disease pathophysiology and immunology, as well as disease treatment, prevention and control. In this fast-moving discipline, there is a need for the scientific community to take the opportunity to meet and review significant progress.
Conference Scope
Session 1:Advances in understanding parasite biology and host-parasite interactions that are relevant to disease and treatment
Session 2:Assimilating genome-wide analyses of parasites to provides new tools for vaccines and drug discovery projects, as well as understanding the mechanisms of resistance
Session 3: Vector biology: New approaches to vector control of plasmodium parasites
Session 4: Emerging parasites: recently discovered knowlesi in humans that is providing new insights into pathophysiology of malarial infections
Session 5: Revisiting the sequestration and cytokine/mediator models for pathogenesis
Session 6: Drug discovery - renewed vision and role in malaria control and elimination
Session 7: Immunology and vaccine development
Session 8: Disease Control: Vector control options are constantly evolving, whether by pesticide, sterile insect technique or biological control. What else is on the horizon?
Audience
Researchers, clinicians, graduate students, post doctoral fellows, health organizations and all who are interested in malaria and public health.
Cutting edge presentations will be delivered by internationally renowned researchers. Short oral platform presentations and posters will be selected from registrants submitted abstracts.
